MedTrace Logo

Low-Dose Endotoxemia and the Acute Phase Response

NCT00197899 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2005-12-13

No results posted yet for this study

Summary

The purpuse of this study is to examine the acute phase respons when different doses of E. Coli Endotoxin is injected in healty volunters.

Conditions

Interventions

DRUG

E. Coli endotoxin

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Bente K Pedersen, MD, DMSc · Department of Infectious Diseases 7641, University Hospital of Copenhagen, H:S Rigshospitalet

  • Dorthe H Olsen, MD · Department of Intensive Care, Herlev University Hospital

  • Dorthe H Olsen, DM · Department of Intensive Care, Herlev University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2005-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00197899 on ClinicalTrials.gov